Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Genet Mol Res ; 13(3): 4820-30, 2014 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-25062417

RESUMEN

We evaluated the effects of glutamine on clastogenic and genotoxic damage prevention caused by the administration of cisplatin. Forty Swiss mice were divided into 8 experimental groups: G1 and G2, which were control groups; G3, G4, and G5, which were administered [2 doses of glutamine (orally)] separated by a 24-h period (150, 300, and 600 mg/kg, respectively), and a dose of phosphate-buffered saline by intraperitoneal injection; G6, G7, and G8, which were treated in the same manner as the previous groups, but received cisplatin rather than phosphate-buffered saline. The antimutagenicity groups showed damage reduction percentages of 79.05, 80.00, and 94.27% at the time point T1, 53.18, 67.05, and 64.74 at time point T2 for the 150, 300, and 600 mg/kg doses of glutamine, respectively. Antigenotoxic activity was evident for all 3 doses with damage reduction percentages of 115.05, 119.06, and 114.38 for the doses of glutamine of 150, 300, and 600 mg/ kg, respectively. These results suggest that further studies are needed to confirm the clastogenic activity of glutamine. However, our results may lead to rational strategies for supplementation of this antioxidant as an adjuvant in cancer treatment or for preventing genomic lesions.


Asunto(s)
Antimutagênicos/farmacología , Antioxidantes/farmacología , Cisplatino/farmacología , Glutamina/farmacología , Mutágenos/farmacología , Animales , Antineoplásicos/farmacología , Cisplatino/antagonistas & inhibidores , Ensayo Cometa , Daño del ADN , Inyecciones Intraperitoneales , Masculino , Ratones , Pruebas de Micronúcleos
2.
Hybridoma ; 15(6): 415-22, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8985752

RESUMEN

The surface glycoprotein gp43, a highly immunogenic component of Paracoccidioides brasiliensis, is used in the serodiagnosis of paracoccidioidomycosis (PCM) and has recently been shown to specifically bind the extracellular matrix protein laminin. Binding to laminin induces the increased adhesion of the fungus to epithelial cells; a hamster testicle infection model has shown that the gp43-dependent binding of fungal cells to laminin enhances their pathogenicity in vivo. We report on the production and characterization of 12 monoclonal antibodies against the gp43 that recognize peptide sequences in the molecule detecting at least three different epitopes as well as different isoforms of this antigen. MAbs interfered in the fungal pathogenicity in vivo either by inhibiting or enhancing granuloma formation and tissue destruction. Results suggest that P. brasiliensis propagules may start infection in man by strongly adhering to human lung cells. Thus, laminin-mediated fungal adhesion to human lung carcinoma (A549) cells was much more intense than to Madin-Darby canine kidney cells (MDCK), indicating differences in binding affinity. Subsequent growth of fungi bound to the lung cells could induce the granulomatous inflammatory reaction characteristic of PCM. Both steps are greatly stimulated by laminin binding in infective cells expressing gp43.


Asunto(s)
Anticuerpos Antifúngicos/farmacología , Anticuerpos Antifúngicos/uso terapéutico , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/farmacología , Antígenos Fúngicos/inmunología , Proteínas Fúngicas , Glicoproteínas/inmunología , Laminina/antagonistas & inhibidores , Laminina/farmacología , Oligosacáridos/inmunología , Paracoccidioides/patogenicidad , Paracoccidioidomicosis/etiología , Animales , Anticuerpos Antifúngicos/inmunología , Anticuerpos Monoclonales/uso terapéutico , Unión Competitiva/inmunología , Adhesión Celular/efectos de los fármacos , Cricetinae , Células Epiteliales , Epitelio/metabolismo , Humanos , Laminina/efectos de los fármacos , Masculino , Paracoccidioides/efectos de los fármacos , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA